Cargando…
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
Monoclonal antibodies are among the most effective tools for detecting tumor-associated antigens. The U.S. Food and Drug Administration (FDA) has approved more than 36 therapeutic antibodies for developing novel alternative therapies that have significant success rates in fighting cancer. However, s...
Autores principales: | Rodríguez-Nava, Cynthia, Ortuño-Pineda, Carlos, Illades-Aguiar, Berenice, Flores-Alfaro, Eugenia, Leyva-Vázquez, Marco Antonio, Parra-Rojas, Isela, del Moral-Hernández, Oscar, Vences-Velázquez, Amalia, Cortés-Sarabia, Karen, Alarcón-Romero, Luz del Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295864/ https://www.ncbi.nlm.nih.gov/pubmed/37371712 http://dx.doi.org/10.3390/biomedicines11061610 |
Ejemplares similares
-
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020) -
scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012) -
“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023) -
Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer
por: Cortés-Sarabia, Karen, et al.
Publicado: (2021) -
Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)